UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Defective membrane repair machinery impairs survival of invasive cancer cells

Scientific reports, 2020-12, Vol.10 (1), p.21821-21821, Article 21821

2020

Volltextzugriff (PDF)

1104 HEPATITIS C VIRUS NON-STRUCTURAL 3/4A PROTEIN EXPRESSION PROMOTES HEPATIC FIBROGENESIS IN MICE AFTER ADMINISTRATION OF CARBON TETRACHLORIDE

Journal of hepatology, 2013-04, Vol.58, p.S451-S451

2013

Volltextzugriff (PDF)

A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells

EMBO molecular medicine, 2022-10, Vol.14 (10), p.e15821-n/a

2022

Volltextzugriff (PDF)

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance

Human vaccines & immunotherapeutics, 2020-01, Vol.16 (2), p.251-268

2020

Volltextzugriff (PDF)

Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination

Gene therapy, 2014-08, Vol.21 (8), p.739-750

2014

Volltextzugriff (PDF)

P183 A THERAPEUTIC VACCINE BASED ON THE HEPATITIS B CORE ANTIGEN IN COMBINATION WITH INTERLEUKIN-12 EFFECTIVELY INDUCES IMMUNE RESPONSES IN HBV-TRANSGENIC MICE

Journal of hepatology, 2014-04, Vol.60 (1), p.S127-S127

2014

Volltextzugriff (PDF)

P202 EVALUATION OF A HEPATITIS C VIRUS THERAPEUTIC VACCINE CANDIDATE IN WILDTYPE- AND HCV-TRANSGENIC MICE

Journal of hepatology, 2014-04, Vol.60 (1), p.S133-S133

2014

Volltextzugriff (PDF)

P216 HEPATITIS C NONSTRUCTURAL PROTEIN 3/4A DAMPENS INFLAMMATION AND CONTRIBUTES TO SLOW FIBROSIS PROGRESSION DURING CHRONIC LIVER INJURY IN MICE

Journal of hepatology, 2014-04, Vol.60 (1), p.S138-S138

2014

Volltextzugriff (PDF)

Relation between viral fitness and immune escape within the hepatitis C virus protease

Gut, 2006-02, Vol.55 (2), p.266-274

2006

Volltextzugriff (PDF)

1247 HIGH CLEARANCE RATE OF VIREMIA IN PATIENTS WITH CHRONIC HEPATITIS C OF GENOTYPE 1 RECEIVING STANDARD-OF-CARE THERAPY FOLLOWING THERAPEUTIC DNA VACCINATION

Journal of hepatology, 2011-03, Vol.54, p.S492-S493

2011

Volltextzugriff (PDF)

761 IN VIVO INTRACELLULAR INJECTION NEEDLE (IVIN) TECHNOLOGY: A NEW NEEDLE FOR IMPROVED CELLULAR UPTAKE OF DNA IN A LIVE ANIMAL

Journal of hepatology, 2011-03, Vol.54, p.S306-S307

2011

Volltextzugriff (PDF)

318 THE HEPATITIS C VIRUS ENHANCES ACTIVATION OF THE EGF-RECEPTOR AND AKT-ACTIVITY BY NS3/4A-MEDIATED CLEAVAGE OF THE T-CELL PROTEIN TYROSINE PHOSPHATASE

Journal of hepatology, 2009, Vol.50, p.S124-S124

2009

Volltextzugriff (PDF)

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes

Gut, 2009-04, Vol.58 (4), p.560-569

2009

Volltextzugriff (PDF)

Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3 4A gene

Gene therapy, 2004-03, Vol.11 (6), p.522-533

2004

Volltextzugriff (PDF)

843 A SYNTHETIC CODON-OPTIMIZED HCV NON-STRUCTURAL 5A DNA VACCINE PRIMES POLYFUNCTIONAL CD8+ T CELL RESPONSES IN WILDTYPE AND NS5A-TRANSGENIC MICE

Journal of hepatology, 2012-04, Vol.56, p.S329-S329

2012

Volltextzugriff (PDF)

770 THE HCV NS3/4A-MEDIATED IMPAIRMENT OF THE HEPATIC ANTIVIRAL IMMUNE RESPONSE IS REVERSED BY PROTEASE INHIBITION OR RIBAVIRIN IN VIVO

Journal of hepatology, 2012-04, Vol.56, p.S302-S302

2012

Volltextzugriff (PDF)

Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients

The Journal of immunology (1950), 2020-11, Vol.205 (9), p.2437-2446

2020

Volltextzugriff (PDF)

The hepatitis C virus and immune evasion:: nonstructural 3/4A transgenic mice are resistant to lethal tumour necrosis factor α mediated liver disease

Gut, 2006-10, Vol.55 (10), p.1475

2006

Volltextzugriff (PDF)

The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor α mediated liver disease

Gut, 2006-10, Vol.55 (10), p.1475-1483

2006

Volltextzugriff (PDF)

680 HCV NS3/4A INTERFERES WITH INTRAHEPATIC IMMUNITY AND TNFA-INDUCED LIVER DAMAGE BY MODULATING CCL17 AND CXCL9 SECRETION IN VIVO

Journal of hepatology, 2010, Vol.52, p.S265-S265

2010

Volltextzugriff (PDF)

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine

Journal of virology, 2020-08, Vol.94 (18), p.e01279

2020

Volltextzugriff (PDF)

Prophylactic vaccine against hepatitis D virus (HDV) superinfection

JOURNAL OF HEPATOLOGY, 2023, Vol.78, p.S1038

2023

Volltextzugriff (PDF)

1207 HETEROLOGOUS T CELLS CAN HELP RESTORE FUNCTION IN DYSFUNCTIONAL HEPATITIS C VIRUS SPECIFIC T CELLS DURING THERAPEUTIC VACCINATION

Journal of hepatology, 2011-03, Vol.54, p.S476-S477

2011

Volltextzugriff (PDF)

681 HCV NS3/4A-MEDIATED CCL2 AND TNFA SECRETION INCREASE HEPATOCYTE SURVIVAL AND LIVER REGENERATION IN VIVO

Journal of hepatology, 2010, Vol.52, p.S265-S265

2010

Volltextzugriff (PDF)

Methods to Evaluate Novel Hepatitis C Virus Vaccines

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1403, p.221

2016

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(183)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(81)
Science & Technology
(77)
Life Sciences & Biomedicine
(67)
Animals
(52)
Humans
(36)
Mice
(33)
Biological And Medical Sciences
(25)
Hepatitis C Virus
(22)
Hepacivirus - Immunology
(18)
Immunology
(18)
Mice, Transgenic
(18)
Female
(16)
Fundamental And Applied Biological Sciences. Psychology
(15)
Gastroenterology And Hepatology
(15)
Medical Sciences
(15)
Biochemistry & Molecular Biology
(14)
Dna
(14)
Hepacivirus - Genetics
(14)
Hepatitis
(14)
Male
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Defective membrane repair machinery impairs survival of invasive cancer cells

1104 HEPATITIS C VIRUS NON-STRUCTURAL 3/4A PROTEIN EXPRESSION PROMOTES HEPATIC FIBROGENESIS IN MICE AFTER ADMINISTRATION OF CARBON TETRACHLORIDE

A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance

Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination

P183 A THERAPEUTIC VACCINE BASED ON THE HEPATITIS B CORE ANTIGEN IN COMBINATION WITH INTERLEUKIN-12 EFFECTIVELY INDUCES IMMUNE RESPONSES IN HBV-TRANSGENIC MICE

P202 EVALUATION OF A HEPATITIS C VIRUS THERAPEUTIC VACCINE CANDIDATE IN WILDTYPE- AND HCV-TRANSGENIC MICE

P216 HEPATITIS C NONSTRUCTURAL PROTEIN 3/4A DAMPENS INFLAMMATION AND CONTRIBUTES TO SLOW FIBROSIS PROGRESSION DURING CHRONIC LIVER INJURY IN MICE

Relation between viral fitness and immune escape within the hepatitis C virus protease

1247 HIGH CLEARANCE RATE OF VIREMIA IN PATIENTS WITH CHRONIC HEPATITIS C OF GENOTYPE 1 RECEIVING STANDARD-OF-CARE THERAPY FOLLOWING THERAPEUTIC DNA VACCINATION

761 IN VIVO INTRACELLULAR INJECTION NEEDLE (IVIN) TECHNOLOGY: A NEW NEEDLE FOR IMPROVED CELLULAR UPTAKE OF DNA IN A LIVE ANIMAL

318 THE HEPATITIS C VIRUS ENHANCES ACTIVATION OF THE EGF-RECEPTOR AND AKT-ACTIVITY BY NS3/4A-MEDIATED CLEAVAGE OF THE T-CELL PROTEIN TYROSINE PHOSPHATASE

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes

Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3 4A gene

843 A SYNTHETIC CODON-OPTIMIZED HCV NON-STRUCTURAL 5A DNA VACCINE PRIMES POLYFUNCTIONAL CD8+ T CELL RESPONSES IN WILDTYPE AND NS5A-TRANSGENIC MICE

770 THE HCV NS3/4A-MEDIATED IMPAIRMENT OF THE HEPATIC ANTIVIRAL IMMUNE RESPONSE IS REVERSED BY PROTEASE INHIBITION OR RIBAVIRIN IN VIVO

Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients

The hepatitis C virus and immune evasion:: nonstructural 3/4A transgenic mice are resistant to lethal tumour necrosis factor α mediated liver disease

The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor α mediated liver disease

680 HCV NS3/4A INTERFERES WITH INTRAHEPATIC IMMUNITY AND TNFA-INDUCED LIVER DAMAGE BY MODULATING CCL17 AND CXCL9 SECRETION IN VIVO

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine

Prophylactic vaccine against hepatitis D virus (HDV) superinfection

1207 HETEROLOGOUS T CELLS CAN HELP RESTORE FUNCTION IN DYSFUNCTIONAL HEPATITIS C VIRUS SPECIFIC T CELLS DURING THERAPEUTIC VACCINATION

681 HCV NS3/4A-MEDIATED CCL2 AND TNFA SECRETION INCREASE HEPATOCYTE SURVIVAL AND LIVER REGENERATION IN VIVO

Methods to Evaluate Novel Hepatitis C Virus Vaccines

Suchergebnisse filtern